| 2024-07-06 |
Delayed diagnosis of tuberous sclerosis complex: Unveiling low-level TSC2 mosaicism using targeted next-generation sequencing |
Clinical and Experimental Dermatology. 2024 Jul 06;Article in Press. |
 |
| 2024-06-19 |
CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity |
Cell Death and Disease. 2024 Jun 19;15(6):Article number 434. |
|
| 2024-04 |
Surgical excision and radiotherapy for brain metastasis from colorectal cancer: How frailty and comorbidity indices influence outcome |
Kaohsiung Journal of Medical Sciences. 2024 Apr;40(4):395-403. |
|
| 2024-01-30 |
Neutralizing IL-16 enhances the efficacy of targeting Aurora-A therapy in colorectal cancer with high lymphocyte infiltration through restoring anti-tumor immunity |
Cell Death and Disease. 2024 Jan 30;15:Article number 103. |
|
| 2023-11 |
Mitochondrial ATP biogenesis regulated by vdac1 in tmem119+tumor-associated microglia and macrophages mediates high-grade glioma growth |
Neuro-Oncology. 2023 Nov;25(Suppl. 5):v286. |
|
| 2023-09-08 |
Multimodal analysis of glioblastoma reveals the potential of cxcr7-cxcl12 in gbm cells sensitizes gbm to immune checkpoint blockade therapy |
Neuro-Oncology. 2023 Sep 08;25(Suppl. 2):ii96-ii97. |
|
| 2023-07-31 |
Role of SH3GLB1 in the regulation of CD133 expression in GBM cells |
BMC Cancer. 2023 Jul 31;23:Article number 713. |
|
| 2023-07-22 |
The complex role of eicosanoids in the brain: Implications for brain tumor development and therapeutic opportunities |
Biochimica et Biophysica Acta. Reviews on Cancer. 2023 Jul 22;1878(5):Article number 188957. |
|
| 2023-05-30 |
A novel combination therapy of arginine deiminase and an arginase inhibitor targeting arginine metabolism in the tumor and immune microenvironment |
American Journal of Cancer Research. 2023 May 30;13(5):1952-1969. |
|
| 2023-04-14 |
Hypoxia in drug resistance and radioresistance |
Hypoxia in Cancer: Significance and Impact on Cancer Therapy. 2023 Apr 14:433-447. |
|
| 2022-07-13 |
SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma |
Journal of Experimental and Clinical Cancer Research. 2022 Jul 13;41:Article number 220. |
|
| 2022-03-25 |
Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation |
Journal of Biomedical Science. 2022 Mar 25;29:Article number 21. |
|
| 2022-02-02 |
HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells |
Journal of Experimental and Clinical Cancer Research. 2022 Feb 2;41:Article number 47. |
|
| 2022-02 |
Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors |
Journal of Clinical Oncology. 2022 Feb;40(4, Suppl.):660. |
|
| 2021-10-19 |
SOD2 enhancement by long-term inhibition of the pi3k pathway confers multi-drug resistance and enhanced tumor-initiating features in head and neck cancer |
International Journal of Molecular Sciences. 2021 Oct 19;22(20):Article number 11260. |
|
| 2021-09-28 |
Histone deacetylase 6 acts upstream of DNA damage response activation to support the survival of glioblastoma cells |
Cell Death and Disease. 2021 Sep 28;12(10):Article number 884. |
|
| 2021-06-12 |
Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers |
Oncoimmunology. 2021 Jun 12;10(1):Article number 1943253. |
|
| 2021-05-14 |
Transferrin modified gsh sensitive hyaluronic acid derivative micelle to deliver hsp90 inhibitors to enhance the therapeutic efficacy of brain cancers |
Cancers. 2021 May 14;13(10):Article number 2375. |
|
| 2021-05 |
A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer |
Gastric Cancer. 2021 May;24(3):624-639. |
|
| 2021-05 |
A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer[Erratum:Gastric Cancer. 2021 May;24(3):624-639.] |
Gastric Cancer. 2021 May;24(3):640-641. |
|
| 2021-04 |
Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors |
Oncologist. 2021 Apr;26(4):e567-e579. |
|
| 2021-03-08 |
Dissecting the mechanism of temozolomide resistance and its association with the regulatory roles of intracellular reactive oxygen species in glioblastoma |
Journal of Biomedical Science. 2021 Mar 8;28:Article number 18. |
|
| 2021-02-24 |
New insights into oral squamous cell carcinoma: From clinical aspects to molecular tumorigenesis |
International Journal of Molecular Sciences. 2021 Feb 24;22(5):Article number 2252. |
|
| 2020-10 |
Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma |
Neuro-Oncology. 2020 Oct;22(10):1439-1451. |
|
| 2020-05-30 |
Oleic acid -induced NOX4 is dependent on ANGPTL4 expression to promote human colorectal cancer metastasis |
Theranostics. 2020 May 30;10(16):7083-7099. |
|
| 2019-10-19 |
Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets |
Journal of Biomedical Science. 2019 Oct 19;26:Article number 77. |
|
| 2019-09-03 |
Role of autophagy in therapeutic resistance of glioblastoma |
Journal of Cancer Metastasis and Treatment. 2019 Sep 3;5:Article number 66. |
|
| 2019-06 |
Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial |
Head and Neck. 2019 Jun;41(6):1703-1712. |
|
| 2018-12 |
The clinical implication of O6 methylguanine DNA methyltransferase in rectal cancers |
Cancer Science. 2018 Dec;109(Suppl. 2):1369. |
|
| 2018-07 |
Mitochondrial SOD2 is the mainstay to protect the stemness-featured glioblastoma cells against drug-induced reactive oxygen stress |
Cancer Research. 2018 Jul;78(13, Suppl.):Meeting Abstract 4887. |
|
| 2018-07 |
Sp1 acetylation associates with stemness characteristics in temozolomide-resistant glioblastoma |
Cancer Research. 2018 Jul;78(13, Suppl.):Meeting Abstract 5905. |
|
| 2018-07 |
Oleic acid promotes head and neck squamous cell carcinoma anoikis resistance and metastasis via ANGPTL4/fibronectin pathway |
Cancer Research. 2018 Jul;78(13, Suppl.):Meeting Abstract 85. |
|
| 2018-05 |
A phase Ib study of ADI-PEG 20 plus pembrolizumab in advanced solid cancers |
Journal of Clinical Oncology. 2018 May;36(15, Suppl. S):Meeting Abstract 2556. |
|
| 2018-01 |
O6BG modulates the repair activity of homologous recombination and its clinical application |
Cancer Science. 2018 Jan;109(Suppl. 1):379. |
|
| 2017-11 |
Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma |
Biochemical and Biophysical Research Communications. 2017 Nov;493(1):14-19. |
|
| 2017-10 |
Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis via up-regulation of fibronectin |
FASEB Journal. 2017 Oct;31(10):4265-4276. |
|
| 2017-08-12 |
Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase |
Redox Biology. 2017 Aug 12;13:655-664. |
|
| 2017-05-22 |
Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma |
Oncogenesis. 2017 May 22;6(5):Article number e339. |
|
| 2017-05 |
A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy |
Journal of Clinical Oncology. 2017 May;35(Suppl. 15):Meeting Abstract 2531. |
|
| 2016-11-18 |
Suberoylanilide hydroxamic acid represses glioma stem-like cells |
Journal of Biomedical Science. 2016 Nov 18;23:Article number 81. |
|
| 2016-07-19 |
MicroRNA-17 modulates regulatory T cell function by targeting co-regulators of the foxp3 transcription factor |
Immunity. 2016 Jul 19;45(1):83-93. |
|
| 2016-02 |
Phase I dose-escalation study of sorafenib plus S-1 in refractory solid tumors |
Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 745. |
|
| 2015-09 |
O6-Methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma |
International Journal of Cancer. 2015 Sep;137(6):1291-1305. |
|
| 2015-08 |
Decrease of ARNT promotes cancer metastasis by activating the fibronectin/integrin beta 1/FAK axis |
Cancer Research. 2015 Aug;75:Abstract number 523. |
|
| 2015-08 |
Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulation |
Cancer Research. 2015 Aug;75(Suppl. 15):Abstract number 4149. |
|
| 2015-07 |
Clinicopathological study of epidermal growth factor receptor inhibitor-induced papulopustular lesions |
British Journal of Dermatology. 2015 Jul;173(Suppl. S1):73. |
|
| 2015-05 |
Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin beta1/FAK axis |
Oncotarget. 2015 May;6(13):11530-11546. |
|
| 2015-03 |
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer |
Oral Diseases. 2015 Mar;21(2):207-215. |
|
| 2014-12-22 |
Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulation |
Oncotarget. 2014 Dec 22;6(3):1723-1739. |
|
| 2014-11 |
The interplay between alcohol consumption, oral hygiene, ALDH2 and ADH1B in the risk of head and neck cancer |
International Journal of Cancer. 2014 Nov;135(10):2424-2436. |
|
